Zevra Therapeutics Other Long Term Assets (Quarterly) Analysis

Zevra Therapeutics, Inc. (ZVRA)

8.80 -0.09 (-1.01%) USD | NASDAQ | Feb 20, 16:00

8.81 +0.01 (+0.11%) After-Hours: 20:00

View Other Long Term Assets (Quarterly) for ZVRA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

Verastem, Inc.	Upgrade
ADMA Biologics, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	Upgrade